| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
|
Lancet
|
2010
|
14.40
|
|
2
|
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
|
Hypertension
|
2003
|
3.29
|
|
3
|
Renal sympathetic-nerve ablation for uncontrolled hypertension.
|
N Engl J Med
|
2009
|
2.97
|
|
4
|
"Stress" and coronary heart disease: psychosocial risk factors.
|
Med J Aust
|
2003
|
2.63
|
|
5
|
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy.
|
Arch Gen Psychiatry
|
2008
|
2.43
|
|
6
|
Renal denervation in moderate to severe CKD.
|
J Am Soc Nephrol
|
2012
|
2.21
|
|
7
|
Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.
|
Hypertension
|
2012
|
2.17
|
|
8
|
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
|
J Hypertens
|
2007
|
2.09
|
|
9
|
Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation.
|
Hypertension
|
2013
|
2.04
|
|
10
|
QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder.
|
Am J Physiol Heart Circ Physiol
|
2008
|
1.85
|
|
11
|
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?
|
J Hypertens
|
2011
|
1.80
|
|
12
|
Sympathetic activation in chronic renal failure.
|
J Am Soc Nephrol
|
2008
|
1.80
|
|
13
|
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
|
Am J Clin Nutr
|
2008
|
1.75
|
|
14
|
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.
|
Hypertension
|
2009
|
1.67
|
|
15
|
Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population.
|
Hypertens Res
|
2008
|
1.66
|
|
16
|
Persistence of muscle sympathetic nerve activity during vasovagal syncope.
|
Eur Heart J
|
2010
|
1.56
|
|
17
|
Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
|
J Hypertens
|
2013
|
1.54
|
|
18
|
Sympathetic and cardiac baroreflex function in panic disorder.
|
J Hypertens
|
2002
|
1.53
|
|
19
|
Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension.
|
Hypertension
|
2012
|
1.52
|
|
20
|
Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
|
J Am Coll Cardiol
|
2004
|
1.51
|
|
21
|
Angiotensin II and norepinephrine release: interaction and effects on the heart.
|
J Hypertens
|
2005
|
1.44
|
|
22
|
Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure.
|
Eur Heart J
|
2005
|
1.43
|
|
23
|
Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer.
|
Clin Endocrinol (Oxf)
|
2002
|
1.40
|
|
24
|
Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
|
J Clin Endocrinol Metab
|
2005
|
1.39
|
|
25
|
Effects of weight loss on renal function in overweight Japanese men.
|
Hypertens Res
|
2011
|
1.39
|
|
26
|
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
|
Circulation
|
2003
|
1.38
|
|
27
|
Mediators of sympathetic activation in metabolic syndrome obesity.
|
Curr Hypertens Rep
|
2008
|
1.29
|
|
28
|
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
|
Diabetes
|
2012
|
1.25
|
|
29
|
Losartan increases bradykinin levels in hypertensive humans.
|
Circulation
|
2005
|
1.25
|
|
30
|
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
|
Circulation
|
2002
|
1.18
|
|
31
|
The role of sympathetic nervous activity in renal injury and end-stage renal disease.
|
Hypertens Res
|
2010
|
1.12
|
|
32
|
Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables.
|
Psychosom Med
|
2006
|
1.10
|
|
33
|
Baroreflex sensitivity: a reliable predictor of response to renal denervation?
|
J Am Coll Cardiol
|
2014
|
1.09
|
|
34
|
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
|
J Am Coll Cardiol
|
2012
|
1.08
|
|
35
|
Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk.
|
Hypertens Res
|
2007
|
1.08
|
|
36
|
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.
|
J Am Coll Cardiol
|
2013
|
1.05
|
|
37
|
Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.
|
J Physiol
|
2011
|
1.03
|
|
38
|
Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.
|
Diabetes
|
2009
|
1.02
|
|
39
|
Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity.
|
Circulation
|
2003
|
1.02
|
|
40
|
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
|
Int J Cardiol
|
2013
|
1.01
|
|
41
|
Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
|
Curr Diabetes Rev
|
2010
|
0.98
|
|
42
|
Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.
|
J Physiol
|
2009
|
0.97
|
|
43
|
Autonomic control of the aging heart.
|
Neuromolecular Med
|
2008
|
0.96
|
|
44
|
Postural syncope: mechanisms and management.
|
Med J Aust
|
2007
|
0.95
|
|
45
|
The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.
|
J Clin Endocrinol Metab
|
2010
|
0.95
|
|
46
|
Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder.
|
Am J Physiol Heart Circ Physiol
|
2009
|
0.94
|
|
47
|
Renal denervation and hypertension.
|
Am J Hypertens
|
2011
|
0.93
|
|
48
|
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.
|
J Hypertens
|
2009
|
0.91
|
|
49
|
Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension.
|
Front Physiol
|
2012
|
0.91
|
|
50
|
Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure.
|
Circulation
|
2002
|
0.89
|
|
51
|
Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.
|
Diabetes
|
2009
|
0.87
|
|
52
|
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure.
|
Eur Heart J
|
2003
|
0.85
|
|
53
|
Renal denervation in human hypertension: mechanisms, current findings, and future prospects.
|
Curr Hypertens Rep
|
2012
|
0.84
|
|
54
|
Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects.
|
J Clin Endocrinol Metab
|
2011
|
0.84
|
|
55
|
Renal denervation: current implications and future perspectives.
|
Clin Sci (Lond)
|
2014
|
0.84
|
|
56
|
Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation.
|
J Hypertens
|
2004
|
0.81
|
|
57
|
Cardiac ablation and renal denervation systems have distinct purposes and different technical requirements.
|
JACC Cardiovasc Interv
|
2013
|
0.80
|
|
58
|
Regional sympathetic effects of low-dose clonidine in heart failure.
|
Hypertension
|
2003
|
0.80
|
|
59
|
Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome.
|
Front Physiol
|
2011
|
0.80
|
|
60
|
Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
|
EuroIntervention
|
2013
|
0.79
|
|
61
|
Recent advances in the treatment of hypertension.
|
Expert Rev Cardiovasc Ther
|
2011
|
0.79
|
|
62
|
Effects of renal denervation on insulin resistance.
|
Expert Rev Cardiovasc Ther
|
2012
|
0.79
|
|
63
|
New therapeutic approaches to resistant hypertension.
|
Curr Hypertens Rep
|
2010
|
0.78
|
|
64
|
Health-related quality of life and blood pressure 12 months after renal denervation.
|
J Hypertens
|
2015
|
0.78
|
|
65
|
Letter by Kaye and Esler regarding article "extracardiac progenitor cells repopulate most major cell types in the transplanted human heart".
|
Circulation
|
2006
|
0.77
|
|
66
|
The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.
|
Obesity (Silver Spring)
|
2013
|
0.76
|
|
67
|
Atrial fibrillation is associated with decreased cardiac sympathetic response to isometric exercise in CHF in comparison to sinus rhythm.
|
Pacing Clin Electrophysiol
|
2008
|
0.75
|
|
68
|
Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension".
|
Circulation
|
2007
|
0.75
|
|
69
|
Response to quality of life after renal denervation.
|
Hypertension
|
2013
|
0.75
|
|
70
|
Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
|
Hypertension
|
2007
|
0.75
|
|
71
|
Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation.
|
J Appl Physiol (1985)
|
2008
|
0.75
|
|
72
|
Acute electrophysiologic effects of intravenous amiodarone are independent of a sympatholytic action in humans.
|
J Cardiovasc Pharmacol
|
2003
|
0.75
|
|
73
|
Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies.
|
Int J Cardiol
|
2011
|
0.75
|
|
74
|
Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?
|
J Hypertens
|
2002
|
0.75
|